Urte Fultinaviciute - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Urte Fultinaviciute's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Urte Fultinaviciute
Verified
Reporter, Citeline
London
Beats
Biography
Healthcare reporter at Clinical Trials Arena and Pharmaceutical Technology, GlobalData Media.
Health And Wellness , Consumer Tech
I'm not that keen on Awareness Weeks ( sorry!)
Content
By Urte Fultinaviciute Verified| Clinical Trials Arena Verified The past year marked significant regulatory updates and changes across the globe, as regulators tried to keep up with the evolving and maturing clinical trial industry. While the US Food and Drug Administration (FDA) finally released its draft guidance on decentralised clinical trials (DCTs) and efforts to improve trial diversity, the European Medicines Agency (EMA) said farewell to the old clinical trial platform for new trial applications.
By Irena Maragkou, Urte Fultinaviciute Verified| Clinical Trials Arena Verified Decentralised clinical trials (DCTs) are often pinned as a silver bullet to increase a trial’s footprint and reach various populations that otherwise would not participate in research. But as the industry takes off its rose-tinted glasses after a few years of hype surrounding DCTs, it is time to evaluate whether decentralisation actually helps improve diversity. One of the most patient-centric methodologies in the DCT toolbox is electronic patient-reported outcomes (ePROs).
By Urte Fultinaviciute Verified| Medical Device Network Verified Delpor is sketching out late-stage clinical trial plans for its drug-device combination implant DLP-114 (risperidone) in schizophrenia. After presenting topline results from a Phase Ib/IIa trial (NCT04418466) in November, the US-based biopharma company is currently making some changes to the product based on the learnings from the previous study, CEO Tassos Nicolaou told Clinical Trials Arena.
Company Info
Citeline
Citeline, part of Norstella, is a global leader in pharmaceutical and medtech business intelligence solutions. The company is dedicated to connecting treatments with patients by providing data-driven insights across clinical, commercial, and regulatory areas. Its mission is to ensure timely access to treatments through evidence-based decision-making tools. Citeline offers a range of specialized solutions, including real-time R&D intelligence, regulatory compliance support, and in-depth analysis of industry trends. Their clinical solutions provide global clinical trial data and tools for protocol design and enrollment benchmarking. Additionally, Citeline enhances patient engagement and recruitment through awareness campaigns and educational resources. The company serves over 180,000 users worldwide, including pharmaceutical companies, biotech firms, and clinical research organizations, supporting professionals throughout the drug development lifecycle. With a global team of analysts and consultants, Citeline curates valuable insights on key diseases and market forecasts, emphasizing a patient-centric approach to address challenges in clinical trials and market competition.
'+1 646-957-8919
Founded: 1997